oxycodone has been researched along with Acute Ischemic Stroke in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bian, W; Han, D; Hu, Y; Shao, F; Shen, Y; Sun, W; Zou, L | 1 |
| Daunert, S; Deo, S; Dikici, E; Peyravian, N; Sun, E; Toborek, M | 1 |
2 other study(ies) available for oxycodone and Acute Ischemic Stroke
| Article | Year |
|---|---|
Oxycodone relieves permeability damage and apoptosis of oxygen-glucose deprivation/reoxygenation-induced brain microvascular endothelial cells through ras homolog family member A (RhoA)/ Rho-associated coiled-coil containing kinases (ROCK)/ myosin light c
Topics: Apoptosis; Brain; Cardiac Myosins; Endothelial Cells; Glucose; Humans; Ischemic Stroke; Myosin Light Chains; Oxycodone; Oxygen; Permeability; Reproducibility of Results; rho-Associated Kinases; rhoA GTP-Binding Protein | 2022 |
Opioid Antagonist Nanodrugs Successfully Attenuate the Severity of Ischemic Stroke.
Topics: Analgesics, Opioid; Animals; Ischemic Stroke; Mice; Morphine; Naloxone; Naltrexone; Nanoparticles; Narcotic Antagonists; Opioid-Related Disorders; Oxycodone; Stroke; Tight Junction Proteins | 2022 |